Beverly J. Lybrand, Merck Vaccines

Adweek's annual #Brandweek summit will explore the ideas behind breakthrough successes, discuss solutions to pressing challenges and explore new opportunities in the Metaverse. Join leaders from Alo Yoga, Hyundai Motor America, Frito-Lay and more, Sept. 12–16 in Miami. Sign up early to save.

By now, you’ve probably heard the heated arguments for and against Merck’s introduction last year of Gardasil-the first, and so far only, vaccine that protects women against the human papillomavirus (HPV), a surprisingly common sexually transmitted disease that is the leading cause of cervical cancer in women. An April op-ed in the Detroit News, for instance, charged that the vaccine promotes promiscuity and “devalues personal morals.”

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in

Your sites feature HTML here...